TRIM47 and intrahepatic cholangiocarcinoma: Collectively, the observations demonstrate that TRIM47 accelerates the progression of ICC by interacting with FH and ubiquitinating FH, indicating that the TRIM47–FH axis may be a potential target for ICC treatment.